MedPath

A randomised controlled trial comparing the Gonadotrophin Releasing Hormone agonist long regimen versus the Gonadotrophin Releasing Hormone agonist short regimen versus the Gonadotrophin Releasing Hormone antagonist regimen in poor responders undergoing in vitro fertilisation treatment

Completed
Conditions
Poor ovarian response in In Vitro Fertilisation (IVF)
Pregnancy and Childbirth
Registration Number
ISRCTN27044628
Lead Sponsor
Guy's and St Thomas' NHS Foundation Trust and King' s College London (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
102
Inclusion Criteria

Any woman undergoing an IVF treatment cycle with or without Intra Cytoplasmic Sperm Injection (ICSI) who is considered to be a poor responder is eligible to participate in the trial.

For this study a poor responder is defined as a woman who had a previous IVF treatment cycle in which she was stimulated with a daily dose of Follicle Stimulating Hormone (FSH) of 300 IU or more for at least nine days and:
1. Produced an inadequate number of mature follicles (three or less follicles measuring more than or equal to 17 mm, or
2. Had three or less oocytes retrieved at oocyte retrieval

Exclusion Criteria

1. Women aged more than 40 years
2. Women with a single ovary

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath